Fixzer-CV Tablet is a potent combination antibiotic containing Cefixime 200mg and Clavulanic Acid 125mg, designed to combat a broad spectrum of bacterial infections. Cefixime, a third-generation cephalosporin, works by inhibiting bacterial cell wall synthesis, leading to the destruction of susceptible bacteria. Clavulanic Acid, a beta-lactamase inhibitor, enhances the efficacy of Cefixime by preventing bacterial enzymes from breaking down the antibiotic, thereby overcoming resistance in beta-lactamase producing strains. This synergistic combination makes Fixzer-CV effective against various infections including respiratory tract infections, urinary tract infections, otitis media, and skin infections caused by both Gram-positive and Gram-negative bacteria. It is typically prescribed when monotherapy with Cefixime may not be sufficient due to resistant organisms. Fixzer-CV should be taken as directed by a healthcare professional, usually orally with or without food, ensuring the full course is completed to prevent resistance development. Common side effects may include gastrointestinal disturbances such as nausea, diarrhea, and abdominal pain, but serious adverse reactions are rare. Patients with a history of hypersensitivity to cephalosporins or penicillins should avoid this medication. Fixzer-CV offers a reliable treatment option for bacterial infections requiring enhanced antibacterial coverage.